Title | Type | SJR | H index | Total Docs. (2000) | Total Docs. (3years) | Total Refs. (2000) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2000) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Drug Resistance Updates | journal | 0.690 Q1 | 132 | 48 | 107 | 2692 | 188 | 99 | 1.76 | 56.08 | |
52 | Journal of Clinical Pharmacology | journal | 0.679 Q1 | 130 | 168 | 467 | 4355 | 973 | 458 | 2.11 | 25.92 | |
53 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 0.652 Q2 | 150 | 97 | 277 | 3406 | 415 | 276 | 1.27 | 35.11 | |
54 | Regulatory Toxicology and Pharmacology | journal | 0.644 Q2 | 123 | 71 | 248 | 2549 | 445 | 225 | 1.32 | 35.90 | |
55 | Journal of Gene Medicine | journal | 0.638 Q2 | 100 | 53 | 54 | 2263 | 118 | 54 | 2.19 | 42.70 | |
56 | Environmental Toxicology | journal | 0.623 Q2 | 90 | 73 | 127 | 1793 | 172 | 125 | 1.38 | 24.56 | |
57 | Clinical Neuropharmacology | journal | 0.622 Q2 | 85 | 60 | 202 | 2082 | 426 | 192 | 2.05 | 34.70 | |
58 | Bioorganic Chemistry | journal | 0.609 Q2 | 86 | 36 | 99 | 980 | 130 | 95 | 1.38 | 27.22 | |
59 | Anti-Cancer Drugs | journal | 0.606 Q2 | 102 | 121 | 399 | 3792 | 669 | 396 | 1.58 | 31.34 | |
60 | Journal of Liquid Chromatography and Related Technologies | journal | 0.605 Q1 | 57 | 238 | 677 | 4535 | 627 | 675 | 0.88 | 19.05 | |
61 | Advances in Drug Research | journal | 0.604 Q2 | 11 | 0 | 9 | 0 | 23 | 9 | 0.00 | 0.00 | |
62 | Medical Letter on Drugs and Therapeutics | journal | 0.575 Q2 | 22 | 57 | 166 | 15 | 174 | 162 | 1.22 | 0.26 | |
63 | Therapeutic Drug Monitoring | journal | 0.558 Q2 | 102 | 130 | 352 | 2981 | 601 | 336 | 1.74 | 22.93 | |
64 | Medicinal Chemistry Research | journal | 0.554 Q1 | 59 | 22 | 142 | 507 | 160 | 139 | 1.29 | 23.05 | |
65 | Alcohol | journal | 0.553 Q2 | 88 | 96 | 275 | 3593 | 403 | 270 | 1.48 | 37.43 | |
66 | Vascular Pharmacology | journal | 0.520 Q2 | 108 | 94 | 689 | 3057 | 926 | 686 | 1.25 | 32.52 | |
67 | Drug Development Research | journal | 0.516 Q2 | 67 | 114 | 245 | 4842 | 358 | 243 | 1.37 | 42.47 | |
68 | Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology | journal | 0.514 Q2 | 121 | 108 | 402 | 3807 | 477 | 399 | 1.33 | 35.25 | |
69 | Bulletin of Environmental Contamination and Toxicology | journal | 0.491 Q2 | 86 | 234 | 759 | 4022 | 490 | 758 | 0.55 | 17.19 | |
70 | Biologicals | journal | 0.466 Q2 | 66 | 32 | 168 | 534 | 153 | 165 | 0.77 | 16.69 | |
71 | Addiction Biology | journal | 0.459 Q2 | 93 | 48 | 130 | 2182 | 156 | 127 | 0.93 | 45.46 | |
72 | Drug Development and Industrial Pharmacy | journal | 0.456 Q2 | 100 | 179 | 485 | 2997 | 388 | 483 | 0.81 | 16.74 | |
73 | PDA Journal of Pharmaceutical Science and Technology | journal | 0.448 Q1 | 43 | 60 | 163 | 713 | 66 | 133 | 0.38 | 11.88 | |
74 | Journal of Biochemical and Molecular Toxicology | journal | 0.433 Q2 | 69 | 44 | 85 | 576 | 107 | 85 | 1.26 | 13.09 | |
75 | Reproductive Toxicology | journal | 0.433 Q2 | 129 | 66 | 241 | 2561 | 309 | 222 | 1.31 | 38.80 | |
76 | Biotechnology and Applied Biochemistry | journal | 0.431 Q3 | 81 | 60 | 200 | 2001 | 248 | 193 | 1.30 | 33.35 | |
77 | Basic and Clinical Pharmacology and Toxicology | journal | 0.429 Q2 | 103 | 106 | 316 | 3228 | 383 | 312 | 1.10 | 30.45 | |
78 | Prostaglandins and Other Lipid Mediators | journal | 0.428 Q2 | 86 | 58 | 222 | 3166 | 358 | 221 | 1.15 | 54.59 | |
79 | Pharmaceutical Development and Technology | journal | 0.416 Q1 | 70 | 67 | 197 | 1247 | 155 | 177 | 0.73 | 18.61 | |
80 | Birth Defects Research Part B - Developmental and Reproductive Toxicology | journal | 0.410 Q2 | 58 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
81 | Pharmaceutical Biotechnology | journal | 0.390 Q2 | 28 | 0 | 54 | 0 | 71 | 54 | 1.37 | 0.00 | |
82 | Journal of Aerosol Medicine and Pulmonary Drug Delivery | journal | 0.389 Q2 | 81 | 43 | 111 | 1417 | 139 | 106 | 1.36 | 32.95 | |
83 | Journal of Pharmacological and Toxicological Methods | journal | 0.389 Q2 | 83 | 56 | 183 | 2614 | 194 | 181 | 0.65 | 46.68 | |
84 | Pharmacological Research | journal | 0.372 Q2 | 169 | 179 | 503 | 5778 | 486 | 500 | 1.02 | 32.28 | |
85 | Journal of Natural Toxins | journal | 0.359 Q3 | 28 | 31 | 77 | 1250 | 69 | 77 | 0.98 | 40.32 | |
86 | Journal of Ocular Pharmacology and Therapeutics | journal | 0.359 Q2 | 72 | 59 | 174 | 1676 | 163 | 173 | 0.94 | 28.41 | |
87 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 0.350 Q2 | 70 | 0 | 106 | 0 | 115 | 100 | 0.99 | 0.00 | |
88 | Artificial Cells, Nanomedicine and Biotechnology | journal | 0.328 Q2 | 86 | 49 | 225 | 1000 | 130 | 216 | 0.37 | 20.41 | |
89 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.328 Q2 | 40 | 75 | 352 | 2504 | 275 | 352 | 0.53 | 33.39 | |
90 | BioPharm International | trade journal | 0.327 Q2 | 32 | 120 | 254 | 740 | 92 | 222 | 0.28 | 6.17 | |
91 | Cardiovascular Drug Reviews | journal | 0.322 Q3 | 54 | 26 | 74 | 888 | 69 | 74 | 0.65 | 34.15 | |
92 | Metal-Based Drugs | journal | 0.320 Q3 | 40 | 47 | 122 | 1291 | 104 | 121 | 0.85 | 27.47 | |
93 | Human and Experimental Toxicology | journal | 0.318 Q3 | 91 | 103 | 357 | 2172 | 330 | 342 | 0.84 | 21.09 | |
94 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.313 Q3 | 68 | 66 | 159 | 2110 | 157 | 141 | 0.88 | 31.97 | |
95 | Natural Toxins | journal | 0.304 Q3 | 49 | 0 | 127 | 0 | 119 | 125 | 0.43 | 0.00 | |
96 | American Journal of Health-System Pharmacy | journal | 0.295 Q3 | 107 | 449 | 1379 | 4207 | 819 | 887 | 0.57 | 9.37 | |
97 | CNS Drug Reviews | journal | 0.282 Q3 | 64 | 23 | 96 | 1454 | 84 | 96 | 0.68 | 63.22 | |
98 | Food and Drug Law Journal | journal | 0.279 Q3 | 23 | 41 | 151 | 4578 | 61 | 151 | 0.41 | 111.66 | |
99 | Pharmaceutical Technology | journal | 0.269 Q2 | 42 | 121 | 295 | 825 | 81 | 274 | 0.25 | 6.82 | |
100 | Dissolution Technologies | journal | 0.258 Q2 | 36 | 14 | 42 | 79 | 14 | 26 | 0.23 | 5.64 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®